Wen-hua Fan

发表

Cleavage and polyadenylation specific factor 4 promotes colon cancer progression by transcriptionally activating hTERT.

W. Guo, Qian Yang, Wenyang Li, 2019, Biochimica et biophysica acta. Molecular cell research.

Molecular subtype identification and prognosis stratification by a metabolism-related gene expression signature in colorectal cancer

Liren Li, D. Lin, J. Peng, 2021, Journal of Translational Medicine.

Surgery with versus without preoperative concurrent chemoradiotherapy for mid/low rectal cancer: an interim analysis of a prospective, randomized trial

P. Ding, Z. Pan, D. Wan, 2015, Chinese journal of cancer.

SPT6 recruits SND1 to co‐activate human telomerase reverse transcriptase to promote colon cancer progression

Ping Guo, Wenyang Li, Y. Zuo, 2020, Molecular oncology.

High WNT6 expression indicates unfavorable survival outcome for patients with colorectal liver metastasis after liver resection

Z. Pan, Xueping Wang, J. Peng, 2019, Journal of Cancer.

Melatonin synergizes BRAF-targeting agent vemurafenib in melanoma treatment by inhibiting iNOS/hTERT signaling and cancer-stem cell traits

Qiang Yang, Ping Guo, W. Guo, 2019, Journal of Experimental & Clinical Cancer Research.

Lymphovascular invasion represents a superior prognostic and predictive pathological factor of the duration of adjuvant chemotherapy for stage III colon cancer patients

Z. Pan, Zhen-hai Lu, Xiaojun Wu, 2020, BMC Cancer.

Feasibility Study of a Modified XELOX Adjuvant Chemotherapy for High-Recurrence Risk Patients With Operated Stage III Colon Cancer

Z. Pan, Xiaoping Lin, J. Peng, 2020, Frontiers in Pharmacology.

Efficacy and safety of a NiTi CAR 27 compression ring for end-to-end anastomosis compared with conventional staplers: A real-world analysis in Chinese colorectal cancer patients

Z. Pan, D. Wan, Zhen-hai Lu, 2016, Clinics.

Ku80 promotes melanoma growth and regulates antitumor effect of melatonin by targeting HIF1-α dependent PDK-1 signaling pathway

T. Kang, Miao Chen, Liren Li, 2019, Redox biology.

Intraoperative Blood Loss Independently Predicts Survival and Recurrence after Resection of Colorectal Cancer Liver Metastasis

P. Ding, Z. Pan, Zhen-hai Lu, 2013, PloS one.

Phase III randomized, placebo‐controlled, double‐blind study of monosialotetrahexosylganglioside for the prevention of oxaliplatin‐induced peripheral neurotoxicity in stage II/III colorectal cancer

Fenghua Wang, P. Ding, Yu-hong Li, 2019, Cancer medicine.

Prognostic value of a novel biomarker combining DNA ploidy and tumor burden score for initially resectable liver metastases from patients with colorectal cancer

Z. Pan, D. Wan, Xiaojun Wu, 2021, Cancer Cell International.

Safety of intraoperative chemotherapy with 5-FU for colorectal cancer patients receiving curative resection: a randomized, multicenter, prospective, phase III IOCCRC trial (IOCCRC)

P. Ding, Z. Pan, D. Wan, 2017, Journal of Cancer Research and Clinical Oncology.

Preoperative AFU Is a Useful Serological Prognostic Predictor for Colorectal Liver Oligometastasis Patients Undergoing Hepatic Resection

Z. Pan, Xiao Luo, Yujie Zhao, 2019, Journal of Cancer.

Prognosis and risk factors for the development of pulmonary metastases after preoperative chemoradiotherapy and radical resection in patients with locally advanced rectal cancer.

Z. Pan, Xiaojun Wu, Cong Li, 2020, Annals of translational medicine.

Patterns of recurrence in patients achieving pathologic complete response after neoadjuvant chemoradiotherapy for rectal cancer

X. An, P. Ding, Z. Pan, 2017, Journal of Cancer Research and Clinical Oncology.

High pretreatment serum CA19-9 level predicts a poor prognosis for patients with stage III colon cancer after curative resection and adjuvant chemotherapy

Z. Pan, D. Wan, Li-ren Li, 2019, Journal of Cancer.

CircMMP1 promotes colorectal cancer growth and metastasis by sponging miR-1238 and upregulating MMP family expression

S. Cai, Yongming Chen, Y-F Bai, 2021, Annals of translational medicine.

Melatonin synergizes BRAF-targeting agent vemurafenib in melanoma treatment by inhibiting iNOS/hTERT signaling and cancer-stem cell traits

W. Guo, Qian Yang, Miao Chen, 2019, Journal of experimental & clinical cancer research : CR.

Total mesorectal excision with or without preoperative chemoradiotherapy for resectable mid/low rectal cancer: a long-term analysis of a prospective, single-center, randomized trial

P. Ding, Z. Pan, D. Wan, 2018, Cancer communications.

Application of Tumor Burden Score for predicting conversion outcome in patients with initially unresectable colorectal liver metastases after first-line systemic therapy

Z. Pan, Xiaojun Wu, Hui Sun, 2021, Therapeutic advances in gastroenterology.

Primary tumor resection with or without metastasectomy for left- and right-sided stage IV colorectal cancer: an instrumental variable analysis

Yi-Chen Yao, J. Peng, W. Fan, 2021, BMC Gastroenterology.

An early report of a screening program for colorectal cancer in Guangzhou, China.

P. Ding, Z. Pan, D. Wan, 2019, Annals of translational medicine.

Evaluation of total tumor volume reduction ratio in initially unresectable colorectal liver metastases after first-line systemic treatment.

Z. Pan, Jiarui He, J. Peng, 2023, European journal of radiology.

Neoadjuvant chemotherapy weakens the prognostic value of the pathological tumor burden score for colorectal cancer liver metastases

Xiaojun Wu, Cong Li, J. Peng, 2023, BMC Surgery.

Surgery with versus without preoperative concurrent chemoradiotherapy for mid/low rectal cancer: an interim analysis of a prospective, randomized trial

P. Ding, Z. Pan, D. Wan, 2015, Chinese journal of cancer.

Circulating tumor DNA analysis predicts recurrence and avoids unnecessary adjuvant chemotherapy in I–IV colorectal cancer

Yuhua Gong, Rongrong Chen, Pengli Yu, 2024, Therapeutic advances in medical oncology.

Mutant KRAS-activated circATXN7 fosters tumor immunoescape by sensitizing tumor-specific T cells to activation-induced cell death

Z. Zeng, J. Peng, Weihao Li, 2024, Nature communications.

Chromosomal instability is associated with prognosis and efficacy of bevacizumab after resection of colorectal cancer liver metastasis.

J. Peng, Yujing Fang, Binyi Xiao, 2024, Annals of medicine.